Brief: Nasdaq Approves Biosergen's Delisting Application
17/09/2026 15:32
BRIEF-Nasdaq Approves Biosergen's Delisting Application Sept 17 (Reuters) - Biosergen AB BIOSGN.ST:
NASDAQ APPROVES BIOSERGEN'S APPLICATION FOR DELISTING FROM FIRST NORTH GROWTH MARKET
DELISTING CONDITIONAL UPON SWEDISH COMPANIES REGISTRATION OFFICE GRANTING PERMISSION TO EXECUTE MERGER WITH FLERIE
LAST DAY OF TRADING IN COMPANY'S SHARES ON NASDAQ FIRST NORTH GROWTH MARKET IS EXPECTED TO BE OCTOBER 21, 2026
Source text: ID:nWkr6hRhbk
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million